NDC 50242-143
Actemra ACTPen
Tocilizumab
Actemra ACTPen is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Tocilizumab.
Product ID | 50242-143_07e066f7-664a-4949-9d91-f8a17e022f45 |
NDC | 50242-143 |
Product Type | Human Prescription Drug |
Proprietary Name | Actemra ACTPen |
Generic Name | Tocilizumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2018-11-19 |
Marketing Category | BLA / BLA |
Application Number | BLA125472 |
Labeler Name | Genentech, Inc. |
Substance Name | TOCILIZUMAB |
Active Ingredient Strength | 180 mg/mL |
Pharm Classes | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |